Authors

Ivan Bastian

MBBS, PhD, FRCPA, Clinical Director, Microbiology Infectious Diseases Directorate, SA Pathology, SA; Councillor, RCPA South Australia, SA


The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19

For the detection of early COVID-19 disease, RCPA supports the use of molecular tests for SARS-CoV-2 and strongly opposes the introduction of COVID-19 IgG/IgM rapid tests for this purpose.